Decreases in circulating tumor DNA (ctDNA) within the first month of immune checkpoint inhibitor (ICI) therapy were strongly ...
In an advance for precision oncology, the largest published study to date on molecular residual disease (MRD) detection in stage 3 colon cancer has demonstrated the prognostic capabilities of Guardant ...
Liquid biopsies, which test body fluids that contain cancerous material, including circulating tumor DNA (ctDNA), are a ...
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced the publication of a new study in npj Precision Oncology highlighting the power of its ...
St. Jude Children’s Research Hospital scientists and multinational collaborators created AI-powered M-PACT to facilitate next ...
St. Jude Children’s Research Hospital scientists have created AI-powered M-PACT to facilitate next-generation classification of pediatric brain tumors by liquid biopsy.
Droplet digital PCR measurements of ctDNA may accurately identify patients with melanoma who are at high risk of recurrence. Patients who were ctDNA positive had worse recurrence-free and overall ...
Circulating tumor DNA (ctDNA) is unreliable for detecting colorectal cancer recurrences after resection, conclude the authors of a review of 48 patients at the City of Hope Comprehensive Cancer Center ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results